FLYNN JAMES E purchased 9.38M shares of LARIMAR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $30.00M. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/4/2025ACC: 0001193805-25-001155
Director10% OwnerOther
Since May 2020
+9.38M
Net shares
Net buyer
$30.00M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9.38M acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+3.39M
Price / share
$3.20
Trade value
$10.84M
% of position
55.1%
7/31/2025
6.15M→9.54M
Common Stock
Indirect
Shares
+3.39M
Price / share
$3.20
Trade value
$10.84M
% of position
55.1%
7/31/2025
6.15M→9.54M
Common Stock
Indirect
Shares
+2.60M
Price / share
$3.20
Trade value
$8.32M
% of position
55.1%
7/31/2025
4.72M→7.32M
Total
Net shares
+9.38M
Net value
$30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/31/2025 | P · Purchase | +3.39M | $3.20 | $10.84M | 55.1% | 6.15M | 9.54M |
| Common Stock Indirect | 7/31/2025 | P · Purchase | +3.39M | $3.20 | $10.84M | 55.1% | 6.15M | 9.54M |
| Common Stock Indirect | 7/31/2025 | P · Purchase | +2.60M | $3.20 | $8.32M | 55.1% | 4.72M | 7.32M |
| Total | +9.38M | $30M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.21M
Total
4.21M indirect4.21M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.21M | Indirect |
| Total | 4.21M | 4.21M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported